Pharma / Biotech

Feds to Push for More Biosimilar Competition



The FDA and the Federal Trade Commission (FTC) announced they will take further action to stem anticompetitive practices that are blocking biosimilars from entering the U.S. market.

Source link

Related posts

CLOBETASOL PROPIONATE Ointment [Lupin Pharmaceuticals,Inc.]

Newsemia

ECHINACEA ANGUSTIFOLIA (Echinacea Angust.) Tablet [STANDARD HOMEOPATHIC COMPANY]

Newsemia

Impact of Precipitation of Antibody Therapeutics following Subcutaneous Injection on Pharmacokinetics and Immunogenicity.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World